Supply Chain Intelligence

Adicet Bio, Inc. Supply Chain

ACET supply chain intelligence for Adicet Bio, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ACET ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

2Suppliers
1Customers
3Debt Items
20Related Chains

Adicet Bio, Inc. Suppliers

TickerNameConfidenceEvidence
COHORT-PHARMACEUTICALS-INC COHORT-PHARMACEUTICALS-INC 85% The Company may pay fees for development and regulatory milestones that together total in the single digit millions of dollars and sales milestones in the low-to-mid double digit millions of dollars.
GDTC CytoMed Therapeutics Limited 72% Reciprocal relationship from GDTC graph: l expansion. ATPL retained the right to use all products and/or services the Company creates which contain or incorporate the modified human K562 cells. Any n…

Adicet Bio, Inc. Customers

TickerNameConfidenceEvidence
GDTC CytoMed Therapeutics Limited 72% Reciprocal relationship from GDTC graph: l expansion. ATPL retained the right to use all products and/or services the Company creates which contain or incorporate the modified human K562 cells. Any n…

Adicet Bio, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ACET-DEBT-7455 Warrants outstanding: 38.3984 90% xbrl warrant detail from xbrl 2025-12-31.
ACET-DEBT Debt stack $13.9M 90% Market cache reports total debt of $13.9M.
ACET-DEBT-7456 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Adicet Bio, Inc. Acquisitions

Acquired EntityNameConfidenceEvidence
ACET-ACQ-0001720580-26-000023 Adicet Bio, Inc. issued a pre-funded warrant to acquire 250,000 shares of common stock. 85% Adicet Bio, Inc. issued a pre-funded warrant to acquire 250,000 shares of common stock.

Adicet Bio, Inc. Ownership

HolderNameConfidenceEvidence
ACET-OWNER-BARCLAYS-PLC BARCLAYS PLC 90% 13F overlay lists BARCLAYS PLC as top holder; 5 tracked holders.

Adicet Bio, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
IBIO iBio, Inc. 100.00 2
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
IMTX Immatics N.V. 100.00 2
BDRX Biodexa Pharmaceuticals Plc 100.00 2
IPSC Century Therapeutics, Inc. 100.00 2
KLRS Kalaris Therapeutics, Inc. 100.00 2
CRBU Caribou Biosciences, Inc. 100.00 2
GILD Gilead Sciences, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
FATE Fate Therapeutics, Inc. 100.00 2
GRAL GRAIL, Inc. 100.00 2
AUTL Autolus Therapeutics plc 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
ARTV Artiva Biotherapeutics, Inc. 100.00 1 ['spend']
CELU Celularity Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 1 ['receiving']
TBPH Theravance Biopharma, Inc. 100.00 2
AZTA Azenta, Inc. 100.00 2
View ACET supply chain intel →

Explore the full interactive supply chain map for Adicet Bio, Inc..

Open ACET supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map